Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management.
Publication/Presentation Date
11-1-2011
Abstract
Primary hyperparathyroidism (PHPT) is the third most common endocrinopathy seen today, and is most frequently found in the 6th to 7th decade of life. PHPT can present with various degrees of symptoms, and can affect many organ systems, including the skeletal, renal, central nervous system and cardiovascular system. Despite this, the most common presentation of hyperparathyroidism is "asymptomatic" with the diagnosis being made incidentally with the initial finding of hypercalcemia on routine laboratory studies, leading to further investigation. Surgical versus medical management is usually based on factors such as age and complications related to hyperparathyroidism (i.e. the presence of renal stones, renal insufficiency and bone loss and significant increases in serum calcium). Treatment options include parathyroidectomy, bisphosphonates, calcitonin and calcimimetics. In this review, we discuss primary hyperparathyroidism in detail with a focus on clinical manifestations particularly in the elderly population. We highlight the indications for surgical versus medical management and compare some of the uses of newer therapeutic agents relative to traditional ones.
Volume
70
Issue
3
First Page
246
Last Page
255
ISSN
1873-4111
Published In/Presented At
Pyram, R., Mahajan, G., & Gliwa, A. (2011). Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management. Maturitas, 70(3), 246–255. https://doi.org/10.1016/j.maturitas.2011.07.021
Disciplines
Medicine and Health Sciences
PubMedID
21943558
Department(s)
Department of Medicine
Document Type
Article